Angelika Muhlebner

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activation.

Associations of cognitive and behavioural impairment in ALS with brain pathology: pTDP-43 versus microglial activation.

Journal: Journal of neurology

Published: March 06, 2026

Exploring brain-glioma interaction: Effect of neuroligin-3 expression on neurocognitive functioning is independent from epilepsy.

Exploring brain-glioma interaction: Effect of neuroligin-3 expression on neurocognitive functioning is independent from epilepsy.

Journal: Neuro-oncology advances

Published: February 03, 2026

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Journal: Nature communications

Published: January 09, 2026

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.

Journal: The Lancet. Haematology

Published: January 08, 2026

Current management of low-grade, epilepsy-associated brain tumors in Europe.

Current management of low-grade, epilepsy-associated brain tumors in Europe.

Journal: Epilepsia

Published: December 29, 2025

TSC-associated microglial hyperactivity: enhanced calcium signaling, metabolism, and phagocytosis.

TSC-associated microglial hyperactivity: enhanced calcium signaling, metabolism, and phagocytosis.

Journal: Acta neuropathologica

Published: September 25, 2025

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 08, 2025

Altered somatostatin receptor 3 expression and functional dysregulation in tuberous sclerosis complex.

Altered somatostatin receptor 3 expression and functional dysregulation in tuberous sclerosis complex.

Journal: Progress in neurobiology

Published: July 21, 2025

Cell-cell communication dysregulation in tuberous sclerosis complex cortical tubers and focal cortical dysplasia.

Cell-cell communication dysregulation in tuberous sclerosis complex cortical tubers and focal cortical dysplasia.

Journal: Acta neuropathologica communications

Published: June 17, 2025

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

Journal: Acta neuropathologica

Published: October 22, 2024

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4.

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation: not simply CNS WHO grade 4.

Journal: Acta neuropathologica

Published: June 20, 2024

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 22, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026